Floe Oral Care, the oral care company dedicated to improving oral and systemic health through a direct-to-consumer subscription, has secured £ 350,000 from a group of leading investors plan, including Holland & Barrett, Lord Mervyn Davies, Tim Farazmand, Professor John Deanfield CBE, Sir Nigel Rudd and Julio Bruno. Existing shareholders Stephen Welton, Dr Jose Navarro and Charles Southey also follow.

Founded by Anglo-Spanish duo Will Welton and Javier Navarro, Floe is an online subscription service whose mission is to fight the ‘dental time bomb’ in the UK by creating a preventative routine for consumers and providing vital information on undetected gum disease.

Will Welton, Co-Founder of Floe Oral Care, said: “If your mouth is the gateway to your body, protecting it requires not only the use of the right products, but also visibility into your health. gums. The impact of gum disease is significant, and the prevalence of periodontitis has barely changed over the past 20 years. Our mission is to create a service that both tracks and improves oral and systemic health. We are keen to foster a proactive relationship with dental care by capturing and contextualizing oral health data, and we are delighted to welcome a fantastic group of business and healthcare investors, as well as a excellent and very relevant business partner. It is a great platform for the next stage of our development.

Periodontitis is now the sixth most common disease in the world and, according to a study by The Economist Intelligence Unit (IEU), costs the UK £ 6.4 billion a year in treatment. Almost half of adults in the UK suffer from some form of periodontal disease, which increasingly increases the risk of serious health problems, including cardiovascular disease and diabetes. Its notoriety, however, remained low among the general public and other healthcare professionals – it is often referred to as a silent killer – the study showing that three in four adults with periodontitis have no idea that they have periodontitis at all. disease.

Tamara Rajah MBE, Chief Business & Science Officer, Holland and Barrett: “H&B is committed to making health and wellness a way of life for all and supporting early innovation in wellness in the part of our strategy. Recognizing that effective oral health management can have a disproportionate impact on an individual’s overall health and well-being, coupled with our interest in the potential of diagnostics, makes Floe very exciting to us. We look forward to working with Will, Javier and the Floe team to optimize the way we manage our oral health and improve lives. “